Page last updated: 2024-10-24

chloroquine and Inflammation

chloroquine has been researched along with Inflammation in 81 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.

Research Excerpts

ExcerptRelevanceReference
"To investigate the effect of chloroquine on airway hyperresponsiveness in asthmatic mice and explore the possible mechanism."7.81[Inhibitory effect of chloroquine on airway hyperresponsiveness in asthmatic mice]. ( Fu, Z; Hu, XY; Liu, EM; Sun, XC; Wang, LJ, 2015)
"Chloroquine (CQ) is a prototypical systemic and intradermal pruritogen for histamine-independent (nonhistaminergic) itch in mice and humans."5.56Characterization of a chloroquine-induced canine model of pruritus and skin inflammation. ( Banovic, F; Blubaugh, A; Denley, T, 2020)
"Inflammation has been associated with dry eye and anti-inflammatory drugs are now being targeted as the alternate therapeutic approach for dry eye condition."5.48Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux. ( Ghosh, A; Jeyabalan, N; Panigrahi, T; Shetty, R; Shivakumar, S; Subramani, M, 2018)
" In fact, two of the actually used drugs against SARS-CoV2, such as chloroquine and the combination lopinavir/ritonavir, might determine a QT (the time from the start of the Q wave to the end of the T wave) interval prolongation and they show several interactions with antiarrhythmic drugs and antipsychotic medications, making them prone to an increased risk of developing arrhythmias."5.12COVID-19 and the burning issue of drug interaction: never forget the ECG. ( Cameli, M; Cameli, P; Franchi, F; Mandoli, GE; Menci, D; Mondillo, S; Sciaccaluga, C; Sisti, N; Valente, S, 2021)
"Although anti-malarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ) are currently used for the treatment of systemic lupus erythematosus, their efficacy for lupus nephritis (LN) remains unclear."4.02Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells. ( Aizawa, T; Imaizumi, T; Kawaguchi, S; Matsumiya, T; Sato, R; Seya, K; Tanaka, H; Tsugawa, K; Watanabe, S, 2021)
"To investigate the effect of chloroquine on airway hyperresponsiveness in asthmatic mice and explore the possible mechanism."3.81[Inhibitory effect of chloroquine on airway hyperresponsiveness in asthmatic mice]. ( Fu, Z; Hu, XY; Liu, EM; Sun, XC; Wang, LJ, 2015)
"The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world."2.66The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. ( Li, T; Liu, Z; Qin, Y; Wang, J; Wang, Q; Yan, X; Zeng, X; Zhang, F; Zhang, S; Zhang, W; Zhang, X; Zhao, Y, 2020)
" The dosing regimen used in preclinical models of nephrotoxicity may impact the success of therapeutic candidates in clinical trials."1.72Pharmacological inhibitors of autophagy have opposite effects in acute and chronic cisplatin-induced kidney injury. ( Beverly, LJ; Doll, MA; Feng, JL; Krueger, AM; Orwick, A; Sears, SM; Shah, PP; Siskind, LJ; Vega, AA, 2022)
"Chloroquine (CQ) is a prototypical systemic and intradermal pruritogen for histamine-independent (nonhistaminergic) itch in mice and humans."1.56Characterization of a chloroquine-induced canine model of pruritus and skin inflammation. ( Banovic, F; Blubaugh, A; Denley, T, 2020)
" The author here is proposing to test 5-FU in combination with a number of deoxynucleosides on animal models infected with this Covid-19."1.565-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. ( Ahmad, SI, 2020)
"We studied RT4 schwannoma cells to investigate the regulation of Fpr2 and TLR9 after stimulation with fMLF as a prototypical formylated peptide."1.56 ( Dubový, P; Korimová, A, 2020)
"Malaria is an infectious disease of major worldwide clinical importance that causes a variety of severe, or complicated, syndromes including cerebral malaria, which is often fatal."1.51Integrin αDβ2 influences cerebral edema, leukocyte accumulation and neurologic outcomes in experimental severe malaria. ( Azevedo-Quintanilha, IG; Bozza, PT; Campbell, RA; Castro-Faria-Neto, HC; Estato, V; Ferreira, AC; Nascimento, DO; Reis, PA; Silva, TI; Vieira-de-Abreu, A; Weyrich, AS; Zimmerman, GA, 2019)
"Inflammation has been associated with dry eye and anti-inflammatory drugs are now being targeted as the alternate therapeutic approach for dry eye condition."1.48Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux. ( Ghosh, A; Jeyabalan, N; Panigrahi, T; Shetty, R; Shivakumar, S; Subramani, M, 2018)
"TAS2R agonists attenuated features of airway remodeling including smooth muscle mass, extracellular matrix deposition and pro-fibrotic signaling, and also prevented mucus accumulation and development of AHR in mice."1.46Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice. ( Deshpande, DA; Knight, MJ; Nayak, AP; Oliver, B; Pan, S; Sharma, P; Tang, F; Wang, N; Yi, R, 2017)
"Chloroquine (CQ) has been shown to affect LPS-TLR4 colocalization and inhibit both MyD88-dependent and TRAM/TRIF-dependent pathways, though the mechanism involved is still poorly understood."1.46Chloroquine attenuates lipopolysaccharide-induced inflammatory responses through upregulation of USP25. ( Ding, C; Li, F; Long, Y; Zheng, J, 2017)

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-199028 (34.57)18.7374
1990's2 (2.47)18.2507
2000's10 (12.35)29.6817
2010's18 (22.22)24.3611
2020's23 (28.40)2.80

Authors

AuthorsStudies
Ukani, R1
Lewis, TC1
Day, TP1
Wu, W2
Malladi, SS1
Warshakoon, HJ1
David, SA1
Hamel, Y1
Mauvais, FX1
Madrange, M1
Renard, P1
Lebreton, C1
Nemazanyy, I1
Pellé, O1
Goudin, N1
Tang, X3
Rodero, MP1
Tuchmann-Durand, C1
Nusbaum, P1
Brindley, DN1
van Endert, P1
de Lonlay, P1
Banga, R1
Banga, V1
Eltalla, A1
Shahin, L1
Parag, S1
Naim, M1
Iyer, E1
Kumrah, N1
Zacharias, B1
Nathanson, L1
Beljanski, V1
Gamea, GA1
Elmehy, DA1
Salama, AM1
Soliman, NA1
Afifi, OK1
Elkaliny, HH1
Abo El Gheit, RE1
El-Ebiary, AA1
Tahoon, DM1
Elkholy, RA1
Shoeib, SM1
Eleryan, MA1
Younis, SS1
Sears, SM1
Feng, JL1
Orwick, A1
Vega, AA1
Krueger, AM1
Shah, PP1
Doll, MA1
Beverly, LJ1
Siskind, LJ1
Wang, J6
Zhao, Y4
Zhang, X8
Tu, W1
Wan, R1
Shen, Y1
Zhang, Y5
Trivedi, R1
Gao, P1
Kartik, S1
Pal, R1
Chaudhary, MJ1
Nath, R1
Kumar, M1
Binwal, M1
Bawankule, DU1
Tan, H2
Cao, L1
Sadeghi, A1
Shabani, M1
Alizadeh, S1
Meshkani, R1
Park, TY1
Jang, Y1
Kim, W1
Shin, J1
Toh, HT1
Kim, CH1
Yoon, HS1
Leblanc, P1
Kim, KS1
Blubaugh, A1
Denley, T1
Banovic, F1
Azevedo-Quintanilha, IG1
Vieira-de-Abreu, A1
Ferreira, AC1
Reis, PA2
Silva, TI1
Nascimento, DO1
Campbell, RA1
Estato, V2
Weyrich, AS1
Bozza, PT2
Zimmerman, GA2
Castro-Faria-Neto, HC2
Lübow, C1
Bockstiegel, J1
Weindl, G1
Hu, TY1
Frieman, M1
Wolfram, J1
Zhang, W1
Zhang, F2
Wang, Q3
Li, T2
Liu, Z3
Qin, Y1
Yan, X1
Zeng, X1
Zhang, S3
Ahmad, SI1
Liao, S1
Tang, S2
Tan, B1
Li, J8
Qi, M1
Cui, Z1
Zha, A1
Wang, Y4
Yin, Y1
Sun, P1
Tang, Y1
Sciaccaluga, C1
Cameli, M1
Menci, D1
Mandoli, GE1
Sisti, N1
Cameli, P1
Franchi, F1
Mondillo, S1
Valente, S1
Podlasin, RB1
Kowalska, JD1
Pihowicz, A1
Wojtycha-Kwaśnica, B1
Thompson, M1
Dyda, T1
Czeszko-Paprocka, H1
Horban, A1
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H4
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X1
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S2
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y2
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C2
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y2
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tao, F1
Xiang, W1
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y3
Chen, L3
Shan, A1
Zhao, H5
Wu, M2
Ma, Q1
Zhang, E1
Zhang, J4
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L3
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Wu, X2
Lu, J2
Li, M1
Li, W2
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q2
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X2
Li, S2
Zhang, M4
Zhang, H2
Yang, T2
Dong, Y1
Xu, Y2
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y5
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C4
Gao, F1
Qi, Y1
Lu, H1
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z2
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X2
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q2
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J2
Guan, H1
Li, D2
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S2
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J1
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y2
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L2
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F2
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H1
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Qian, G1
Korimová, A1
Dubový, P1
Matangila, JR1
Nyembu, RK1
Telo, GM1
Ngoy, CD1
Sakobo, TM1
Massolo, JM1
Muyembe, BM1
Mvwala, RK1
Ilunga, CK1
Limbole, EB1
Ntalaja, JM1
Kongo, RM1
Sato, R1
Imaizumi, T1
Aizawa, T1
Watanabe, S2
Tsugawa, K1
Kawaguchi, S1
Seya, K1
Matsumiya, T1
Tanaka, H1
Ogah, OS1
Umuerri, EM1
Adebiyi, A1
Orimolade, OA1
Sani, MU1
Ojji, DB1
Mbakwem, AC1
Stewart, S1
Sliwa, K1
Tripathy, S1
Pramanik, P1
Saha, B1
Roy, S1
Sharma, P1
Yi, R1
Nayak, AP1
Wang, N1
Tang, F1
Knight, MJ1
Pan, S1
Oliver, B1
Deshpande, DA1
Ye, W1
Yang, Z1
Jin, J1
Lyu, J1
Wu, F1
Wei, X1
Hu, A1
Tong, S1
Gong, F1
Xie, L1
Xiao, J1
Shivakumar, S1
Panigrahi, T1
Shetty, R1
Subramani, M1
Ghosh, A1
Jeyabalan, N1
Liu, J1
Kang, R1
Tang, D1
Bernard, MA1
Han, X1
Inderbitzin, S1
Agbim, I1
Koziel, H1
Tachado, SD1
Thomé, R1
Bombeiro, AL1
Issayama, LK1
Rapôso, C1
Lopes, SC1
da Costa, TA1
Di Gangi, R1
Ferreira, IT1
Longhini, AL1
Oliveira, AL1
da Cruz Höfling, MA1
Costa, FT1
Verinaud, L1
Sun, XC1
Hu, XY1
Wang, LJ1
Liu, EM1
Fu, Z1
Cui, CM1
Gao, JL1
Sun, LQ1
Wang, YC1
Wang, KJ1
Li, R1
Tian, YX1
Cui, JZ1
Margalef, P1
Colomer, C1
Villanueva, A1
Montagut, C1
Iglesias, M1
Bellosillo, B1
Salazar, R1
Martínez-Iniesta, M1
Bigas, A1
Espinosa, L1
Ding, C1
Long, Y1
Shen, H1
Wu, N1
Zhao, M1
Leelahavanichkul, A1
Yasuda, H1
Doi, K1
Zhou, H1
Yuen, PS1
Star, RA1
Glinsky, GV1
Filler, R1
Saha, R1
Zhang, C1
Gao, X1
Dykema, KJ1
Martin, KR1
Ke, J1
Hudson, EA1
Khoo, SK1
Resau, JH1
Alberts, AS1
MacKeigan, JP1
Furge, KA1
Xu, HE1
da Silva, TI1
d'Avila, JC1
Siqueira, LD1
Assis, EF1
Bozza, FA1
Tibiriça, EV1
Park, J1
Kwon, D1
Choi, C1
Oh, JW1
Benveniste, EN1
CHIRICO, G1
FALCHI, F1
TRNAVSKY, K1
TRNAVSKA, Z1
MALINSKY, J1
LAPAROVA, V1
BOSTROEM, H1
BERNTSEN, K1
WHITEHOUSE, MW1
ADAM, M2
HOUBA, V2
STOJAN, B2
WARLEY, MA1
HAMILTON, PJ1
MARSDEN, PD1
BROWN, RE1
MERSELIS, JG1
WILKS, N1
Nosal, R1
Navarro, M1
Fraile, G1
Velásquez, M1
González, E1
Escalona, J1
Ilanjian, R1
Abad, MJ1
Taylor, P1
Matsukura, S1
Kokubu, F1
Kurokawa, M1
Kawaguchi, M1
Ieki, K1
Kuga, H1
Odaka, M1
Suzuki, S1
Homma, T1
Takeuchi, H1
Nohtomi, K1
Adachi, M1
Flach, AJ1
D'Arcy, PF1
Howard, EM1
Lanham, JG1
Hughes, GR1
Binderup, L1
Bramm, E1
Arrigoni-Martelli, E1
Tsega, E1
Damtew, B1
Landells, JW1
Besrat, A1
Seyoum, E1
Martínez-Rueda, JO1
Arce-Salinas, CA1
Kraus, A1
Alcocer-Varela, J1
Alarcón-Segovia, D1
Potvin, F1
Petitclerc, E1
Marceau, F1
Poubelle, PE1
Fassbender, K1
Schneider, S1
Bertsch, T1
Schlueter, D1
Fatar, M1
Ragoschke, A1
Kühl, S1
Kischka, U1
Hennerici, M1
Yew, NS1
Wu, IH1
Song, A1
Tousignant, JD1
Przybylska, M1
Cheng, SH1
Lammers, G1
Jamieson, JC1
Pfaltzgraff, RE1
Yoshioka, A1
Miyachi, Y1
Imamura, S1
Connolly, KM1
Stecher, VJ1
Danis, E1
Pruden, DJ1
LaBrie, T1
Raghoebar, M1
van den Berg, WB1
van Ginneken, CA1
Coles, RS1
Roubal, Z1
Grimová, J1
Nĕmecek, O1
Cepelák, V1
Perper, RJ1
Sanda, M1
Chinea, G1
Oronsky, AL1
Seiler, K1
Danysz, A1
Mizushima, Y1
Tsukada, W1
Akimoto, T1
Behrend, T1
Gieldanowski, J1
Pelczarska, A1
Seel, DJ1
Yang, J1
Lee, KY1
Jobin, F1
Gagnon, FT1
Pick, E1
Brostoff, J1
Krejci, J1
Turk, JL1
Stone, OJ2
Willis, CJ1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency[NCT04007562]0 participants (Actual)Observational2019-07-31Withdrawn (stopped due to The study never started)
Efficacy and Safety of the Use of Hydroxychloroquine, Favipiravir or Hydroxychloroquine + Favipiravir in Early SARS-CoV-2 (COVID-19) Treatment[NCT04981379]Phase 31,120 participants (Actual)Interventional2020-11-16Completed
Nutritional Habits, Does it Affect Coronavirus Disease 2019 (COVID-19) Infection Outcome? An Egyptian Experience[NCT04447144]200 participants (Anticipated)Observational2020-06-01Recruiting
Evaluation of Independent Clinical- Laboratory Predictors of Clinical Outcomes in Hospitalized Positive SARS-CoV2 Patients (Outcomes SARS-CoV2)[NCT05162534]1,800 participants (Actual)Observational2020-05-29Completed
Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis[NCT04920851]23 participants (Anticipated)Observational2021-06-10Recruiting
"A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression (the ACLR8-LR Study)"[NCT05947812]Phase 2148 participants (Anticipated)Interventional2023-08-01Not yet recruiting
Pirfenidone Effect on the Recovery of Renal Function in Patients With Septic Acute Kidney Injury[NCT02530359]Phase 490 participants (Anticipated)Interventional2015-10-31Not yet recruiting
Effects of Early Atorvastatin Treatment During the Acute Phase of Stroke on Immunoinflammatory Markers and Outcome in Patients With Acute Ischemic Stroke Classified as LAAS According TOAST Classification[NCT02225834]Phase 450 participants (Actual)Interventional2011-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for chloroquine and Inflammation

ArticleYear
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
    Clinical immunology (Orlando, Fla.), 2020, Volume: 214

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir

2020
COVID-19 and the burning issue of drug interaction: never forget the ECG.
    Postgraduate medical journal, 2021, Volume: 97, Issue:1145

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
    Global heart, 2021, 03-15, Volume: 16, Issue:1

    Topics: Acute Coronary Syndrome; Africa; Antimalarials; Arrhythmias, Cardiac; Cardiovascular Diseases; Chlor

2021
Antiplatelet and antileukocyte effects of cardiovascular, immunomodulatory and chemotherapeutic drugs.
    Cardiovascular & hematological agents in medicinal chemistry, 2006, Volume: 4, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Blood Platelets; Cardiovascular Agents; Chlo

2006
Antimalarial therapy in SLE.
    Clinics in rheumatic diseases, 1982, Volume: 8, Issue:1

    Topics: Antimalarials; Binding Sites; Chloroquine; Corneal Diseases; Dose-Response Relationship, Drug; Femal

1982
Ocular manifestations of connective tissue disease.
    Hospital practice (Office ed.), 1985, Feb-15, Volume: 20, Issue:2

    Topics: Adrenal Cortex Hormones; Child; Chloroquine; Connective Tissue Diseases; Eye Diseases; Female; Giant

1985
[Mechanism of action of non-steroid anti-inflammatory agents].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1971, Jul-01, Volume: 24, Issue:13

    Topics: Acid-Base Equilibrium; Adenosine Triphosphatases; Anti-Inflammatory Agents; Ascorbic Acid; Autacoids

1971

Trials

1 trial available for chloroquine and Inflammation

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021

Other Studies

73 other studies available for chloroquine and Inflammation

ArticleYear
Potent adjuvantic activity of a CCR1-agonistic bis-quinoline.
    Bioorganic & medicinal chemistry letters, 2012, Jan-01, Volume: 22, Issue:1

    Topics: Animals; Cattle; Chloroquine; Dose-Response Relationship, Drug; Humans; Immunoglobulin G; Inflammati

2012
Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysis.
    Cell reports. Medicine, 2021, 08-17, Volume: 2, Issue:8

    Topics: Autophagosomes; Child; Child, Preschool; Chloroquine; DNA, Mitochondrial; Endosomes; Female; Follow-

2021
Effects of autophagy modulators tamoxifen and chloroquine on the expression profiles of long non-coding RNAs in MIAMI cells exposed to IFNγ.
    PloS one, 2022, Volume: 17, Issue:4

    Topics: Autophagy; Chloroquine; Humans; Inflammation; Interferon-gamma; RNA, Long Noncoding; Tamoxifen

2022
Direct and indirect antiparasitic effects of chloroquine against the virulent RH strain of Toxoplasma gondii: An experimental study.
    Acta tropica, 2022, Volume: 232

    Topics: Alanine Transaminase; Animals; Antiparasitic Agents; Aspartate Aminotransferases; Caspase 3; Chloroq

2022
Pharmacological inhibitors of autophagy have opposite effects in acute and chronic cisplatin-induced kidney injury.
    American journal of physiology. Renal physiology, 2022, 09-01, Volume: 323, Issue:3

    Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Autophagy; Chloroquine; Cisplatin; Fibrosis; In

2022
Type II alveolar epithelial cell aryl hydrocarbon receptor protects against allergic airway inflammation through controlling cell autophagy.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Allergens; Alveolar Epithelial Cells; Animals; Asthma; Autophagy; Basic Helix-Loop-Helix Transcripti

2022
Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
    Inflammopharmacology, 2023, Volume: 31, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autophagy; Chloroquine; Disease Models, Anima

2023
Acinetobacter baumannii outer membrane protein A induces autophagy in bone marrow-derived dendritic cells involving the PI3K/mTOR pathway.
    Immunity, inflammation and disease, 2023, Volume: 11, Issue:4

    Topics: Acinetobacter baumannii; Animals; Autophagy; Beclin-1; Bone Marrow; Chloroquine; Dendritic Cells; In

2023
Interplay between oxidative stress and autophagy function and its role in inflammatory cytokine expression induced by palmitate in skeletal muscle cells.
    Cytokine, 2020, Volume: 125

    Topics: Acetylcysteine; Adenine; Animals; Autophagy; Cell Line; Chloroquine; Cytokines; Free Radical Scaveng

2020
Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases.
    Scientific reports, 2019, 10-29, Volume: 9, Issue:1

    Topics: Autoimmune Diseases; Autoimmunity; Cell Differentiation; Chloroquine; Cyclic AMP Response Element-Bi

2019
Characterization of a chloroquine-induced canine model of pruritus and skin inflammation.
    Veterinary dermatology, 2020, Volume: 31, Issue:2

    Topics: Administration, Intravenous; Animals; Chloroquine; Cross-Over Studies; Disease Models, Animal; Dogs;

2020
Integrin αDβ2 influences cerebral edema, leukocyte accumulation and neurologic outcomes in experimental severe malaria.
    PloS one, 2019, Volume: 14, Issue:12

    Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; CD11 Antigens; Chloroquine; Disease Models, Animal

2019
Lysosomotropic drugs enhance pro-inflammatory responses to IL-1β in macrophages by inhibiting internalization of the IL-1 receptor.
    Biochemical pharmacology, 2020, Volume: 175

    Topics: Autophagy; Cell Culture Techniques; Cell Survival; Chloroquine; Chlorpromazine; Endocytosis; Fluoxet

2020
Insights from nanomedicine into chloroquine efficacy against COVID-19.
    Nature nanotechnology, 2020, Volume: 15, Issue:4

    Topics: Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Trea

2020
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.
    Medical hypotheses, 2020, Volume: 142

    Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronaviru

2020
Chloroquine Improves Deoxynivalenol-Induced Inflammatory Response and Intestinal Mucosal Damage in Piglets.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Amine Oxidase (Copper-Containing); Animals; Antioxidants; Autophagy; Cadherins; Chloroquine; Cytokin

2020
How to follow-up a patient who received tocilizumab in severe COVID-19: a case report.
    European journal of medical research, 2020, Aug-27, Volume: 25, Issue:1

    Topics: Adult; Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus In

2020
Autophagy inhibition protects from alveolar barrier dysfunction in LPS-induced ALI mice by targeting alveolar epithelial cells.
    Respiratory physiology & neurobiology, 2021, Volume: 283

    Topics: Acute Lung Injury; Adenine; Alveolar Epithelial Cells; Animals; Autophagy; Bronchoalveolar Lavage Fl

2021
    Cells, 2020, 12-11, Volume: 9, Issue:12

    Topics: Animals; Cell Line, Tumor; Chloroquine; Inflammation; N-Formylmethionine Leucyl-Phenylalanine; Neuri

2020
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Adult; Aged; Blood Coagulation; Chloroquine; Coinfection; Comorbidity; Cough; COVID-19; COVID-19 Dru

2020
Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells.
    Renal failure, 2021, Volume: 43, Issue:1

    Topics: Antimalarials; Cell Line; Cells, Cultured; Chemokine CCL5; Chemokines; Chloroquine; Endothelial Cell

2021
A novel nano-anti-malarial induces redox damage and elicits cytokine response to the parasite.
    Cytokine, 2021, Volume: 144

    Topics: Animals; Antimalarials; Cells, Cultured; Chitosan; Chloroquine; Cytokines; Drug Resistance; Humans;

2021
Bitter Taste Receptor Agonists Mitigate Features of Allergic Asthma in Mice.
    Scientific reports, 2017, 04-11, Volume: 7

    Topics: Airway Remodeling; Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Flu

2017
Plasma-derived exosomes contribute to inflammation via the TLR9-NF-κB pathway in chronic heart failure patients.
    Molecular immunology, 2017, Volume: 87

    Topics: Base Sequence; Cells, Cultured; Chloroquine; DNA, Mitochondrial; Exosomes; Gene Dosage; Heart Failur

2017
Chloroquine Promotes the Recovery of Acute Spinal Cord Injury by Inhibiting Autophagy-Associated Inflammation and Endoplasmic Reticulum Stress.
    Journal of neurotrauma, 2018, 06-15, Volume: 35, Issue:12

    Topics: Animals; Autophagy; Chloroquine; Endoplasmic Reticulum Stress; Female; Inflammation; Neuroprotective

2018
Chloroquine Protects Human Corneal Epithelial Cells from Desiccation Stress Induced Inflammation without Altering the Autophagy Flux.
    BioMed research international, 2018, Volume: 2018

    Topics: Autophagy; Chloroquine; Cornea; Dry Eye Syndromes; Epithelium, Corneal; Humans; Inflammation; Matrix

2018
The release and activity of HMGB1 in ferroptosis.
    Biochemical and biophysical research communications, 2019, 03-05, Volume: 510, Issue:2

    Topics: Animals; Autophagy; Carbolines; Cell Death; Cell Line, Tumor; Chloroquine; Ferritins; Fibroblasts; H

2019
HIV-derived ssRNA binds to TLR8 to induce inflammation-driven macrophage foam cell formation.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Antibodies, Neutralizing; Bronchoalveolar Lavage Fluid; Chloroquine; Endocytosis; Endosomes; Foam Ce

2014
Exacerbation of autoimmune neuro-inflammation in mice cured from blood-stage Plasmodium berghei infection.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chloroquine; Encephalomyelitis, Aut

2014
[Inhibitory effect of chloroquine on airway hyperresponsiveness in asthmatic mice].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2015, Volume: 35, Issue:1

    Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Chloroquine; Dexamethasone; Dinoprost; Disease Models

2015
Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death.
    Molecular medicine reports, 2015, Volume: 12, Issue:2

    Topics: Animals; Antigens, Nuclear; Autophagy; Biomarkers; Brain Edema; Brain Injuries; Chloroquine; Disease

2015
BRAF-induced tumorigenesis is IKKα-dependent but NF-κB-independent.
    Science signaling, 2015, Apr-21, Volume: 8, Issue:373

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neopla

2015
Chloroquine attenuates lipopolysaccharide-induced inflammatory responses through upregulation of USP25.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:5

    Topics: Active Transport, Cell Nucleus; Animals; Cell Nucleus; Chloroquine; Gene Knockout Techniques; Gene S

2017
Chloroquine attenuates paraquat-induced lung injury in mice by altering inflammation, oxidative stress and fibrosis.
    International immunopharmacology, 2017, Volume: 46

    Topics: Actins; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Chloroquine; Cytokines; Humans; Inflam

2017
Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice.
    American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:6

    Topics: Acrylates; Animals; Cecum; Chloroquine; Inflammation; Kidney; Kidney Function Tests; Kinetics; Ligat

2008
SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways.
    Cell cycle (Georgetown, Tex.), 2008, Nov-15, Volume: 7, Issue:22

    Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; alpha Karyopherins; Apoptosis

2008
Fluorine in medicinal chemistry: a century of progress and a 60-year retrospective of selected highlights.
    Future medicinal chemistry, 2009, Volume: 1, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chloroqui

2009
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.
    Science signaling, 2011, Jul-05, Volume: 4, Issue:180

    Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Chloroquine; Cytokines; Glucocorticoids; Inf

2011
Could chloroquine conquer autoimmune disorders and inflammation?
    Immunotherapy, 2011, Volume: 3, Issue:9

    Topics: Animals; Autoimmune Diseases; Chloroquine; Humans; Inflammation

2011
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria.
    PLoS pathogens, 2012, Volume: 8, Issue:12

    Topics: Animals; Brain; CD11b Antigen; Chemokines; Chloroquine; Cognition Disorders; Cytokines; Edema; Endot

2012
Chloroquine induces activation of nuclear factor-kappaB and subsequent expression of pro-inflammatory cytokines by human astroglial cells.
    Journal of neurochemistry, 2003, Volume: 84, Issue:6

    Topics: Ammonium Chloride; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Astrocytes; Cells, Cult

2003
[Influence of chloroquine on reactive phlogosis caused by turpentine in guinea pigs].
    Archivio per le scienze mediche, 1960, Volume: 110

    Topics: Animals; Chloroquine; Guinea Pigs; Inflammation; Turpentine

1960
[The effect of resochin on biochemical changes in inflamed tissue].
    Zeitschrift fur Vererbungslehre, 1961, Volume: 92

    Topics: Chloroquine; Granuloma; Humans; Inflammation

1961
BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
    Biochemical pharmacology, 1964, Volume: 13

    Topics: Adenosine Triphosphate; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Antipyrine; Autoradio

1964
[EFFECT OF RESOCHIN ON STERILE AND INFECTIOUS EXPERIMENTAL INFLAMMATION].
    Casopis lekaru ceskych, 1964, May-08, Volume: 103

    Topics: Anti-Infective Agents; Chloroquine; Edema; Granuloma; Inflammation; Neisseria; Penicillins; Rats; Re

1964
CHEMOPROPHYLAXIS OF HOMOZYGOUS SICKLERS WITH ANTIMALARIALS AND LONG-ACTING PENICILLIN.
    British medical journal, 1965, Jul-10, Volume: 2, Issue:5453

    Topics: Adolescent; Anemia; Anemia, Sickle Cell; Antimalarials; Biomedical Research; Chemoprevention; Child;

1965
[ANTIBACTERIAL ACTION OF RESOCHIN AND EXPERIMENTAL INFLAMMATION].
    Zeitschrift fur Rheumaforschung, 1964, Volume: 23

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Chloroquine; Inflammation; Pharmacology; Rats; Rese

1964
Effect of a gold-chloroquine complex on inflammation-related leukocyte functions and cell viability. Comparison with auranofin.
    Arzneimittel-Forschung, 2006, Volume: 56, Issue:12

    Topics: Animals; Antirheumatic Agents; Auranofin; Cell Proliferation; Cell Survival; Chloroquine; Female; Go

2006
Role of RIG-I, MDA-5, and PKR on the expression of inflammatory chemokines induced by synthetic dsRNA in airway epithelial cells.
    International archives of allergy and immunology, 2007, Volume: 143 Suppl 1

    Topics: Bronchi; Cell Line, Transformed; Chemokine CCL5; Chemokine CXCL10; Chemokines, CXC; Chloroquine; DEA

2007
Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquine.
    Transactions of the American Ophthalmological Society, 2007, Volume: 105

    Topics: Arthritis, Rheumatoid; Chloroquine; Humans; Hydroxychloroquine; Inflammation; Informed Consent; Lupu

2007
A new anti-inflammatory test, utilizing the chorio-allantoic membrane of the chick embryo.
    British journal of pharmacology and chemotherapy, 1967, Volume: 29, Issue:3

    Topics: Abnormalities, Drug-Induced; Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethaso

1967
The effect of some antirheumatic drugs in vivo on the response of spleen cells to concanavalin A in rats with chronic inflammation.
    International journal of immunopharmacology, 1982, Volume: 4, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Aspirin; Chloroquine; Chronic Disease; Concanavalin A; Female; Go

1982
The liver in Ethiopians with porphyria cutanea tarda.
    East African medical journal, 1982, Volume: 59, Issue:10

    Topics: Adult; Aged; Alcohol Drinking; Biopsy; Chloroquine; Ethiopia; Female; Humans; Inflammation; Liver; L

1982
Factors associated with fetal losses in severe systemic lupus erythematosus.
    Lupus, 1996, Volume: 5, Issue:2

    Topics: Adult; Analysis of Variance; Azathioprine; Case-Control Studies; Chloroquine; Cohort Studies; Congen

1996
Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells.
    Journal of immunology (Baltimore, Md. : 1950), 1997, Feb-15, Volume: 158, Issue:4

    Topics: Antimalarials; Apoptosis; Cell Division; Cells, Cultured; Chloroquine; Endothelium, Vascular; Fibrob

1997
Temporal profile of release of interleukin-1beta in neurotrauma.
    Neuroscience letters, 2000, Apr-28, Volume: 284, Issue:3

    Topics: Animals; Brain; Brain Injuries; Chloroquine; Colchicine; Immunohistochemistry; Inflammation; Interfe

2000
Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2000, Volume: 1, Issue:3

    Topics: Administration, Intranasal; Animals; Antimalarials; Bronchoalveolar Lavage Fluid; Chloroquine; CpG I

2000
Studies on the effect of lysosomotropic agents on the release of Gal beta 1-4GlcNAc alpha-2,6-sialytransferase from rat liver slices during the acute-phase response.
    The Biochemical journal, 1989, Jul-15, Volume: 261, Issue:2

    Topics: Acute-Phase Reaction; Ammonium Chloride; Animals; beta-D-Galactoside alpha 2-6-Sialyltransferase; Ch

1989
The management of reaction in leprosy.
    International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association, 1989, Volume: 57, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Aspirin; Benzenesulfonates; Chloroquine

1989
The mechanism of the inhibitory effects of antimalarials on UV-induced skin inflammation in mice.
    The Journal of dermatology, 1988, Volume: 15, Issue:2

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Chloroquine; Ear, External; Edema; Female; Inflammatio

1988
Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.
    Agents and actions, 1988, Volume: 25, Issue:1-2

    Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experi

1988
Alteration of chloroquine accumulation in human polymorphonuclear leucocytes under inflammatory conditions.
    International journal of tissue reactions, 1987, Volume: 9, Issue:3

    Topics: Chloroquine; Exocytosis; Humans; Hydrogen-Ion Concentration; Inflammation; Kinetics; Lysosomes; Neut

1987
Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
    Acta Universitatis Carolinae. Medica. Monographia, 1972, Volume: 53

    Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cell Membrane; Chloroquine; Coumarins; Depressio

1972
Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation.
    The Journal of laboratory and clinical medicine, 1974, Volume: 84, Issue:3

    Topics: Animals; Bucladesine; Carrageenan; Chemotaxis; Chloroquine; Chlorpromazine; Chromium Radioisotopes;

1974
[Tests of antiphlogistics in an immunological inflammation in chickens].
    Archives internationales de pharmacodynamie et de therapie, 1967, Volume: 169, Issue:2

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Chickens; Chloroquine; Histamine H1 Antagonists; Immu

1967
A modification of rat adjuvant arthritis for testing antirheumatic drugs.
    The Journal of pharmacy and pharmacology, 1972, Volume: 24, Issue:10

    Topics: Adjuvants, Immunologic; Aminopyrine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthr

1972
[What is assured in the treatment of chronic inflammatory joint disease?].
    Der Internist, 1972, Volume: 13, Issue:12

    Topics: Chloroquine; Chronic Disease; Gold; Humans; Immunosuppressive Agents; Inflammation; Joint Diseases;

1972
Mediators and nonsteroid antiinflammatory drugs in immunologically specific and nonspecific inflammatory processes.
    Archivum immunologiae et therapiae experimentalis, 1971, Volume: 19, Issue:1

    Topics: Adjuvants, Immunologic; Aminopyrine; Animals; Anti-Inflammatory Agents; Arthritis; Bradykinin; Chlor

1971
Inflammatory hemobilia.
    Surgery, 1969, Volume: 66, Issue:5

    Topics: Adult; Aspartate Aminotransferases; Biliary Tract; Biliary Tract Diseases; Chloroquine; Cholangiogra

1969
Platelet reactions and immune processes. IV. The inhibition of complement by pyrazole compounds and other inhibitors of platelet reactions.
    Canadian journal of microbiology, 1970, Volume: 16, Issue:2

    Topics: Animals; Blood Coagulation; Blood Platelets; Chloroquine; Complement Inactivator Proteins; Erythrocy

1970
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors.
    Cellular immunology, 1970, Volume: 1, Issue:1

    Topics: Animals; Antigens; Ascitic Fluid; Cell Migration Inhibition; Cells, Cultured; Chloramphenicol; Chlor

1970
Chloroquine enhancement of inflammation.
    Texas reports on biology and medicine, 1968,Summer, Volume: 26, Issue:2

    Topics: Animals; Chloroquine; Dimethyl Sulfoxide; Inflammation; Phosphates; Pyridoxine; Rabbits; Skin

1968
Early cellular inflammation and neoplasia control.
    Texas reports on biology and medicine, 1968,Fall, Volume: 26, Issue:3

    Topics: Arsenic; Carcinogens; Chloroquine; Folliculitis; Infections; Inflammation; Neoplasms; Psoriasis; Ski

1968